Literature DB >> 11280759

Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.

P M Winter1, H Poptani, N Bansal.   

Abstract

The effects of chemotherapy [25 mg/kg 1,3-bis(2-chloroethyl)-1-nitrosourea administered with a single i.p. injection] on cellular energetics by 31P nuclear magnetic resonance (NMR) spectroscopy, total tissue sodium by single-quantum (SQ) 23Na NMR spectroscopy, and intracellular sodium by triple-quantum-filtered (TQF) 23Na NMR spectroscopy were studied in the s.c. 9L glioma. Animals were studied by NMR 2 days before therapy and 1 and 5 days after therapy. Destructive chemical analysis was also performed 5 days after therapy to validate the origin of changes in SQ and TQF 23Na signals. One day after treatment, there was no significant difference between control and treated tumors in terms of tumor size or 23Na and 31P spectral data. Five days after therapy, treated tumors had 28 +/- 16% (P < 0.1) lower SQ 23Na signal intensity, 46 +/- 20% (P < 0.05) lower TQF 23Na signal intensity, 125 +/- 51% (P < 0.05) higher ATP:Pi ratio, 186 +/- 69% (P < 0.05) higher phosphocreatine:Pi ratio, and 0.17 +/- 0.06 pH units (P < 0.05) higher intracellular pH compared with control tumors. No significant differences in TQF 23Na relaxation times were seen between control and treated tumors at any time point. Destructive chemical analysis showed that the relative extracellular space of control and treated tumors was identical, but the treated tumors had 21 +/- 8% (P < 0.05) lower total tissue Na+ concentration and 60 +/- 24% (P < 0.05) lower intracellular Na+ concentration compared with the controls. The higher phosphocreatine:Pi and ATP:Pi ratios after 1,3-bis(2-chloroethyl)-1-nitrosourea treatment indicate improved bioenergetic status in the surviving tumor cells. The decrease in SQ and multiple-quantum-filtered 23Na signal intensity was largely attributable to a decrease in Na(i)+ because the treatment did not change the relative extracellular space. The improved energy metabolism could decrease the intracellular concentration of Na+ by increasing the activity of Na+-K+-ATPase and decreasing the activity of Na+/H+. Although both 23Na and 31P spectra were consistent with improved cellular metabolism in treated tumors, the 23Na methods may be better suited for monitoring response to therapy because of higher signal:noise ratio and ease of imaging the single 23Na resonance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280759

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  23Na multiple quantum filtered NMR characterisation of Na+ binding and dynamics in animal cells: a comparative study and effect of Na+/Li + competition.

Authors:  Carla P Fonseca; Luís L Fonseca; Liliana P Montezinho; Paula M Alves; Helena Santos; M Margarida C A Castro; Carlos F G C Geraldes
Journal:  Eur Biophys J       Date:  2013-04-06       Impact factor: 1.733

2.  Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors.

Authors:  Victor D Schepkin; Thomas L Chenevert; Kyle Kuszpit; Kuei C Lee; Charles R Meyer; Timothy D Johnson; Alnawaz Rehemtulla; Brian D Ross
Journal:  Magn Reson Imaging       Date:  2006-01-26       Impact factor: 2.546

3.  In vivo magnetic resonance imaging of sodium and diffusion in rat glioma at 21.1 T.

Authors:  Victor D Schepkin; Fabian Calixto Bejarano; Thomas Morgan; Shannon Gower-Winter; Manuel Ozambela; Cathy W Levenson
Journal:  Magn Reson Med       Date:  2011-07-11       Impact factor: 4.668

4.  Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer.

Authors:  Michael A Jacobs; Vered Stearns; Antonio C Wolff; Katarzyna Macura; Pedram Argani; Nagi Khouri; Theodore Tsangaris; Peter B Barker; Nancy E Davidson; Zaver M Bhujwalla; David A Bluemke; Ronald Ouwerkerk
Journal:  Acad Radiol       Date:  2010-09-21       Impact factor: 3.173

5.  Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors.

Authors:  Andriy M Babsky; Shahryar K Hekmatyar; Hong Zhang; James L Solomon; Navin Bansal
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

6.  Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study.

Authors:  Elke Hattingen; Alina Jurcoane; Oliver Bähr; Johannes Rieger; Jörg Magerkurth; Sandra Anti; Joachim P Steinbach; Ulrich Pilatus
Journal:  Neuro Oncol       Date:  2011-09-02       Impact factor: 12.300

7.  Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma.

Authors:  Victor D Schepkin; Brian D Ross; Thomas L Chenevert; Alnawaz Rehemtulla; Surabhi Sharma; Mahesh Kumar; Jadranka Stojanovska
Journal:  Magn Reson Med       Date:  2005-01       Impact factor: 4.668

Review 8.  Sodium homeostasis in the tumour microenvironment.

Authors:  Theresa K Leslie; Andrew D James; Fulvio Zaccagna; James T Grist; Surrin Deen; Aneurin Kennerley; Frank Riemer; Joshua D Kaggie; Ferdia A Gallagher; Fiona J Gilbert; William J Brackenbury
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-07-23       Impact factor: 10.680

9.  Chemosensitivity assay in mice prostate tumor: Preliminary report of flow cytometry, DNA fragmentation, ion ratiometric methods of anti-neoplastic drug monitoring.

Authors:  Rakesh Sharma; Richard Kline
Journal:  Cancer Cell Int       Date:  2004-03-19       Impact factor: 5.722

Review 10.  23 Na-MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis.

Authors:  Linda Osei Poku; M Phil; Yongna Cheng; Kai Wang; Xilin Sun
Journal:  J Magn Reson Imaging       Date:  2020-03-26       Impact factor: 4.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.